Mark Mercola

Mark Mercola

Stanford University

H-index: 71

North America-United States

About Mark Mercola

Mark Mercola, With an exceptional h-index of 71 and a recent h-index of 39 (since 2020), a distinguished researcher at Stanford University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Cardiogenic mesoderm formation regulators

Role of MAPK11 in the protective mechanisms against toxicity of tyrosine kinase inhibitors

Open-source algorithm for high-throughput, non-contact elasticity measurements of IPSC-derived cardiomyocytes

Graphene-based multi-modal sensors

Inhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged mdx/utrn haploinsufficient (+/−) mice

Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration

Abstract P1042: Stem Cell Models Reveal Sarcomere Inhibition As A Potential Treatment For Pediatric Restrictive Cardiomyopathy

Action potential heterogeneity in the myosin binding protein C3 mutant, R943x

Mark Mercola Information

University

Position

___

Citations(all)

15649

Citations(since 2020)

5087

Cited By

12351

hIndex(all)

71

hIndex(since 2020)

39

i10Index(all)

152

i10Index(since 2020)

97

Email

University Profile Page

Stanford University

Google Scholar

View Google Scholar Profile

Top articles of Mark Mercola

Title

Journal

Author(s)

Publication Date

Cardiogenic mesoderm formation regulators

2023/11/21

Role of MAPK11 in the protective mechanisms against toxicity of tyrosine kinase inhibitors

Cancer Research

Anna Pavlovna Hnatiuk

David Staudt

Mark Mercola

2024/3/22

Open-source algorithm for high-throughput, non-contact elasticity measurements of IPSC-derived cardiomyocytes

Biophysical Journal

Adithan Kandasamy

Ricardo Serrano

Mark Mercola

Juan Carlos del Alamo

2024/2/8

Graphene-based multi-modal sensors

2024/1/23

Inhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged mdx/utrn haploinsufficient (+/−) mice

Molecular Therapy-Nucleic Acids

Sacha V Kepreotis

Jae Gyun Oh

Mina Park

Jimeen Yoo

Cholong Lee

...

2024/6/11

Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration

Edward H Wood

Alexander Kreymerman

Tia Kowal

David Buickians

Yang Sun

...

2023/9/1

Abstract P1042: Stem Cell Models Reveal Sarcomere Inhibition As A Potential Treatment For Pediatric Restrictive Cardiomyopathy

Circulation Research

David Staudt

Ricardo Serrano

Mark Mercola

2023/8/4

Action potential heterogeneity in the myosin binding protein C3 mutant, R943x

Biophysical Journal

Mena Abdelsayed

Mark Mercola

2023/2/10

A deep learning platform to assess drug proarrhythmia risk

Cell stem cell

Ricardo Serrano

Dries AM Feyen

Arne AN Bruyneel

Anna P Hnatiuk

Michelle M Vu

...

2023/1/5

Patient-Derived Stem Cell Models of Pediatric Restrictive Cardiomyopathy Exhibit Increased Resting Tension and Cardiomyocyte Calcium Sensitivity

Circulation

David Staudt

Ricardo Serrano

Sho Ozaki Tan

Dries Feyen

Mark Mercola

2023/11/7

Genetic analysis and multimodal imaging identify novel mtDNA 12148T> C leading to multisystem dysfunction with tissue-specific heteroplasmy

medRxiv

Kinsley Belle

Alex Kreymerman

Nirmal Vadgama

Sandeep Randhawa

Juan Caicedo

...

2023

Metabolic maturation increases susceptibility to hypoxia-induced damage in human iPSC-derived cardiomyocytes

Stem cells translational medicine

Marijn C Peters

Renee GC Maas

Iris van Adrichem

Pieter AM Doevendans

Mark Mercola

...

2022/10/1

Phenotypic drug discovery: recent successes, lessons learned and new directions

Fabien Vincent

Arsenio Nueda

Jonathan Lee

Monica Schenone

Marco Prunotto

...

2022/12

Reengineering ponatinib to minimize cardiovascular toxicity

Cancer research

Anna P Hnatiuk

Arne AN Bruyneel

Dhanir Tailor

Mallesh Pandrala

Arpit Dheeraj

...

2022/8/3

Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy

European Heart Journal

Isaac Perea-Gil

Timon Seeger

Arne AN Bruyneel

Vittavat Termglinchan

Emma Monte

...

2022/9/21

Publisher Correction: Phenotypic drug discovery: recent successes, lessons learned and new directions

Fabien Vincent

Arsenio Nueda

Jonathan Lee

Monica Schenone

Marco Prunotto

...

2022/7

Decreasing the High Risk of Ponatinib-Induced Cardiovascular Toxicity in Chronic Myeloid Leukemia

Circulation

Anna P Hnatiuk Hnatiuk

Arne A Bruyneel

Dhanir Taylor

Mallesh Pandrala

Arpit Dheeraj

...

2022/11/8

Abstract LB077: Reengineering ponatinib to minimize cardiovascular toxicity

Cancer Research

Anna Pavlovna Hnatiuk

Arne A Bruyneel

Dhanir Taylor

Mallesh Pandrala

Arpit Dheeraj

...

2022/6/15

A Novel Patient-Derived Stem Cell Model of Restrictive Cardiomyopathy Exhibits Impaired Cardiomyocyte Relaxation Secondary to Increased Myocardial Calcium Sensitivity

Circulation

David Staudt

Ricardo Serrano

Dries Feyen

Mark Mercola

2022/11/8

Designing novel BCR-ABL inhibitors for chronic myeloid leukemia with improved cardiac safety

Journal of medicinal chemistry

Mallesh Pandrala

Arne Antoon N Bruyneel

Anna P Hnatiuk

Mark Mercola

Sanjay V Malhotra

2022/8/9

See List of Professors in Mark Mercola University(Stanford University)